Clinical Trial: Observation of Perioperative FOLFIRINOX for Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Pancreatic Ductal Adenocarcinoma
Study Type: INTERVENTIONAL
Official Title: Perioperative Irinotecan Combined With Oxaliplatin and 5-Fluoracil/Folinic Acid (FOLFIRINOX) For Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma (PHOLIPANC): A P
Brief Summary:
This is a Phase II, Open-Label, Single Arm trial investigating the outcomes of neoadjuvant FOLFIRINOX chemotherapy in patients with hepatic or pulmonary oligometastatic pancreatic adenocarcinoma.
Read more